Annual Accounts Payable
$4.36 M
+$2.91 M+200.34%
December 31, 2023
Summary
- As of February 7, 2025, KYTX annual accounts payable is $4.36 million, with the most recent change of +$2.91 million (+200.34%) on December 31, 2023.
- During the last 3 years, KYTX annual accounts payable has risen by +$3.58 million (+463.78%).
- KYTX annual accounts payable is now at all-time high.
Performance
KYTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$9.93 M
+$5.07 M+104.32%
September 30, 2024
Summary
- As of February 7, 2025, KYTX quarterly accounts payable is $9.93 million, with the most recent change of +$5.07 million (+104.32%) on September 30, 2024.
- Over the past year, KYTX quarterly accounts payable has increased by +$5.57 million (+127.90%).
- KYTX quarterly accounts payable is now at all-time high.
Performance
KYTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
KYTX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +200.3% | +127.9% |
| 3 y3 years | +463.8% | +127.9% |
| 5 y5 years | +463.8% | +127.9% |
KYTX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +463.8% | at high | +584.5% |
| 5 y | 5-year | at high | +463.8% | at high | +584.5% |
| alltime | all time | at high | +463.8% | at high | +584.5% |
Kyverna Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.93 M(+104.3%) |
| Jun 2024 | - | $4.86 M(-34.8%) |
| Mar 2024 | - | $7.45 M(+71.0%) |
| Dec 2023 | $4.36 M | $4.36 M(+44.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $3.02 M(+108.3%) |
| Dec 2022 | $1.45 M(+87.7%) | - |
| Dec 2022 | - | $1.45 M |
| Dec 2021 | $773.00 K | - |
FAQ
- What is Kyverna Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Kyverna Therapeutics?
- What is Kyverna Therapeutics annual accounts payable year-on-year change?
- What is Kyverna Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Kyverna Therapeutics?
- What is Kyverna Therapeutics quarterly accounts payable year-on-year change?
What is Kyverna Therapeutics annual accounts payable?
The current annual accounts payable of KYTX is $4.36 M
What is the all time high annual accounts payable for Kyverna Therapeutics?
Kyverna Therapeutics all-time high annual accounts payable is $4.36 M
What is Kyverna Therapeutics annual accounts payable year-on-year change?
Over the past year, KYTX annual accounts payable has changed by +$2.91 M (+200.34%)
What is Kyverna Therapeutics quarterly accounts payable?
The current quarterly accounts payable of KYTX is $9.93 M
What is the all time high quarterly accounts payable for Kyverna Therapeutics?
Kyverna Therapeutics all-time high quarterly accounts payable is $9.93 M
What is Kyverna Therapeutics quarterly accounts payable year-on-year change?
Over the past year, KYTX quarterly accounts payable has changed by +$5.57 M (+127.90%)